Novalis-based SBRT for Lung Malignancies: Normal Tissue Toxicity and Clinical Outcomes


Bahman Emami, MD, from the department of Radiation Oncology and Thoracic and Cardiovascular Surgery at Loyola University in Chicago presents a retrospective study about Novalis-based Stereotactic Body Radiation Therapy (SBRT) for lung malignancies specifically relating to normal tissue toxicity and clinical outcomes.

About the speaker

Bahman Emami, MD

Bahman Emami, MD
Loyola University, USA


Related Videos

  • Novalis SBRT for Primary and Metastatic Lung Cancers

    Novalis SBRT for Primary and Metastatic Lung Cancers

    Bin S. Teh, MD
    The Methodist Hospital, USA
    Show video

  • SBRT for Extra-Cranial Metastases

    SBRT for Extra-Cranial Metastases

    Casey Chollet, MD
    Loyola University Medical Center, USA
    Show video

  • Tumor Response to Ablative Radiotherapy (SBRT): Use of Novalis for Irradiation in Pre-Clinical Models

    Tumor Response to Ablative Radiotherapy (SBRT): Use of Novalis for Irradiation in Pre-Clinical Models

    Timothy D. Solberg, PhD
    University of California San Francisco, San Francisco, USA
    Show video

  • High Dose Hypofractionated IMRT (HD-HPF-IMRT) for Hepatocellular Carcinoma (HCC)

    High Dose Hypofractionated IMRT (HD-HPF-IMRT) for Hepatocellular Carcinoma (HCC)

    Chitti R. Moorthy, MD
    Westchester Medical Center / New York Medical College, USA
    Show video

  • SBRT Program for “Radioresistant” Renal Cell Carcinoma (RCC): from Genes, Bench to Bedside and Back

    SBRT Program for “Radioresistant” Renal Cell Carcinoma (RCC): from Genes, Bench to Bedside and Back

    Bin S. Teh, MD
    The Methodist Hospital, USA
    Show video

  • The Geometric Accuracy of Frameless SRS Using a 6D Robotic Couch

    The Geometric Accuracy of Frameless SRS Using a 6D Robotic Couch

    T. Takakura
    Kyoto University Hospital, Japan
    Show video

  • Novalis Stereotactic RT for Spinal Metastases

    Novalis Stereotactic RT for Spinal Metastases

    Yoshimasa Mori, MD
    Shin-Yurigaoka General Hospital, Kawasaki, Japan
    Show video

  • Survival Time After RS and hfSRT of Brain Metastases

    Survival Time After RS and hfSRT of Brain Metastases

    Gunnar Surber
    Helios Klinikum Erfurt, Germany
    Show video


Back

Interested in watching this clinical talk? Please click on the button “WATCH Video” to enter your contact details and to have access to two additional videos from the member-only Novalis Circle. Your contact information will only be used to contact you about Novalis Video related updates.

WATCH Video

Keep Watching

Thank you for watching! Please enter your contact details below to continue watching and to have access to two additional videos from the member-only Novalis Circle. Your contact information will only be used to contact you about Novalis Circle video related updates.

  • Please read the following notice
    I have read the privacy policy. I agree that my information and data will be collected and stored electronically in order to answer my enquiry. Please note: You can revoke your consent at any time with effect for the future by emailing legal@brainlab.com.

Watch video No Thanks

Already Novalis Circle Member?

Member Login

Register now

Thank you for your interest in our Novalis Circle videos. Full-access to the media library is currently available for Novalis Radiosurgery users only. If you are a customer, please register or login to continue.

Register Now Login